Literature DB >> 33574312

Sex specific cognitive differences in Parkinson disease.

Tyler Harrison Reekes1,2, Christopher Ian Higginson3, Christina Raye Ledbetter2,4, Niroshan Sathivadivel2,5, Richard Matthew Zweig5, Elizabeth Ann Disbrow6,7,8.   

Abstract

Parkinson disease (PD) is a progressive neurodegenerative disorder that is 1.5 times more common in males than in females. While motor progression tends to be more aggressive in males, little is known about sex difference in cognitive progression. We tested the hypothesis that there are sex differences in cognitive dysfunction in non-demented PD. We evaluated 84 participants (38 females) with PD and 59 controls (27 females) for demographic variables and cognitive function, including attention, working memory, executive function, and processing speed. Multivariate ANOVA revealed no significant differences between groups for demographic variables, including age, years of education, global cogntition, daytime sleepiness, predicted premorbid IQ, UPDRS score, PD phenotype, or disease duration. For cognitive variables, we found poorer performance in males versus females with PD for measures of executive function and processing speed, but no difference between male and female controls. Specifically, PD males showed greater deficits in Verbal Fluency (category fluency, category switching, and category switching accuracy), Color Word Interference (inhibition), and speed of processing (SDMT). There were no differences in measures of working memory or attention across sex and inconsistent findings for switching. Our data indicate that males with PD have significantly greater executive and processing speed impairments compared to females despite no differences in demographic variables or other measures of disease severity. Our findings are consistent with the steeper slope of disease progression reported in males with PD.

Year:  2020        PMID: 33574312     DOI: 10.1038/s41531-020-0109-1

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  48 in total

1.  [Course of the postoperative period in infants with suppurative lung diseases].

Authors:  L E Kotovich; T E Apukhtina
Journal:  Vestn Khir Im I I Grek       Date:  1976-12

Review 2.  Non-motor symptoms in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Parkinsonism Relat Disord       Date:  2015-09-03       Impact factor: 4.891

3.  Perceived and performance-based executive dysfunction in Parkinson's disease.

Authors:  Kimberly E Lanni; Jessica M Ross; Christopher I Higginson; Elizabeth M Dressler; Karen A Sigvardt; Lin Zhang; Norika Malhado-Chang; Elizabeth A Disbrow
Journal:  J Clin Exp Neuropsychol       Date:  2014-03-10       Impact factor: 2.475

4.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Executive functions in Parkinson's disease: systematic review and meta-analysis.

Authors:  Aleksandra Kudlicka; Linda Clare; John V Hindle
Journal:  Mov Disord       Date:  2011-10-03       Impact factor: 10.338

Review 7.  Cognitive and Psychiatric Disturbances in Parkinsonian Syndromes.

Authors:  Richard M Zweig; Elizabeth A Disbrow; Vijayakumar Javalkar
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

Review 8.  What causes mental dysfunction in Parkinson's disease?

Authors:  Murat Emre
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

Review 9.  Cognitive dysfunction and dementia in Parkinson disease.

Authors:  Nuria Caballol; Maria J Martí; Eduardo Tolosa
Journal:  Mov Disord       Date:  2007-09       Impact factor: 10.338

10.  Resting state functional connectivity is associated with cognitive dysfunction in non-demented people with Parkinson's disease.

Authors:  E A Disbrow; O Carmichael; J He; K E Lanni; E M Dressler; L Zhang; N Malhado-Chang; K A Sigvardt
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.